-
STEMart launches Acute Systemic Toxicity testing for the medical device industry.
Mar 22, 2022
-
Thermo Fisher Scientific Inc., the world leader in serving science, today announced its collaboration with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative, Helix, and Rosalind aimed at developing a new genotyping method for SARS-CoV-2 that could speed up the identification of variants as they emerge.
Mar 22, 2022
-
Mar 17, 2022
-
Mar 22, 2022
-
GenNext Technologies, Inc. has announced the receipt of a two-year, Phase II SBIR grant of $2.5 million, for a project titled "In-Cell Automated Flash Oxidation (IC-AutoFox™) Protein Footprinting System."
Mar 23, 2022
-
BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be presenting initial results from two of its hepatocyte research projects at the 2022 Society of Toxicology Annual Meeting and ToxExpo. The conference will be held from March 27-31 both virtually and in person in San Diego, CA.
Mar 23, 2022
-
Mar 24, 2022
-
BOC Sciences optimizes its PROTAC platform of protein degradation technology to boost PROTAC research and development.
Mar 27, 2022
-
Mar 27, 2022
-
Mar 27, 2022
-
Mar 27, 2022
-
VERICHEM releases multi-level set of liquid stable and ready-to-use clinical reference materials for the calibration and calibration verification of Ammonia assays with extended shelf-life stability claims.
Mar 27, 2022
-
Mar 28, 2022
-
Mar 28, 2022
-
Mar 28, 2022
-
Creative Biogene unveils its comprehensive services of bacterial genome editing for worldwide pharmaceutical partners after the self-optimization of homologous recombination technology and the CRISPR/Cas9 platform.
Mar 28, 2022
-
Mar 28, 2022
-
Earlier this month, CD Formulation announces that it is now capable of providing nitrosamine impurities analysis service for customers who are involved with drug formulation projects and need help from CRO companies like CD Formulation.
Apr 6, 2022
-
Apr 3, 2022
-
This transaction expands BioIVT’s donor network and increases its capacity to provide fresh whole blood, plasma, serum, and red blood cells for drug and diagnostic development.
Apr 3, 2022